Company Overview and News

 
New Look Vision Group Inc Reports Record Results for the Second Quarter of 2018

2018-08-09 globenewswire
MONTRÉAL, Aug. 09, 2018 (GLOBE NEWSWIRE) -- New Look Vision Group Inc. ("New Look Vision" or the "Company") (TSX: BCI), a leader in the Canadian retail optical industry with 376 stores across Canada, reported financial results today for the 13 and 26 week periods ended June 30, 2018 (“Q2 2018”). This press release should be read in conjunction with the Company’s management discussion and analysis (the “MD&A") and interim consolidated financial statements for the second quarter of 2018, which are available on the Company’s website at http://www.
BCI

 
Groupe Vision New Look inc. annonce des résultats record pour le deuxième trimestre de 2018

2018-08-09 globenewswire
MONTRÉAL, 09 août 2018 (GLOBE NEWSWIRE) -- Groupe Vision New Look Inc. (TSX: BCI) (« Vision New Look » ou la « société ») a annoncé aujourd’hui ses résultats financiers pour les périodes de 13 et 26 semaines terminées le 30 juin 2018. Groupe Vision New Look est un chef de fil dans le commerce canadien de vente au détail de l’optique avec 376 magasins à travers le Canada. Ce communiqué devrait être lu à la lumière du rapport de gestion et des états financiers consolidés intermédiaires résumés du deuxième trimestre de 2018, lesquels sont disponibles sur le site de la société à http://www.
BCI

 
Appel conférence du Groupe Vision New Look inc. résultats du deuxième trimestre de l’exercice financier 2018

2018-08-01 globenewswire
MONTRÉAL, 01 août 2018 (GLOBE NEWSWIRE) -- Le vendredi 10 août prochain à 12h00 (HAE), le Groupe Vision New Look inc. (TSX:BCI) (« New Look ») présentera ses résultats financiers du deuxième trimestre 2018 lors d’une conférence téléphonique pour la communauté financière. L’annonce des résultats financiers se fera par le biais d’un communiqué qui sera diffusé sur le fil de presse avant la conférence téléphonique.
BCI

 
New Look Vision Group Inc. to Hold Second Quarter 2018 Results Conference Call

2018-08-01 globenewswire
MONTREAL, Aug. 01, 2018 (GLOBE NEWSWIRE) -- New Look Vision Group Inc. (TSX:BCI) ("New Look") announced today that it will present its second quarter results for 2018 during a conference call on Friday, August 10th, 2018 at 12:00 p.m. EDT for the financial community. The financial results will be made public in a press release that will be issued on the newswire prior to the conference call. The Press Release and the Management’s Discussion & Analysis will be posted SEDAR (www.
BCI

 
Groupe Vision New Look Inc. annonce l’élection des administrateurs

2018-05-10 globenewswire
MONTRÉAL, 10 mai 2018 (GLOBE NEWSWIRE) -- Groupe Vision New Look Inc. (TSX:BCI) (« Vision New Look ») a annoncé aujourd’hui que les candidats dont le nom figure dans la circulaire de sollicitation de procurations par la direction datée du 29 mars 2018 ont été élus à titre d’administrateurs de Vision New Look. Voici les résultats détaillés du vote pour l’élection des administrateurs qui a eu lieu à l’assemblée annuelle des actionnaires de Vision New Look plus tôt aujourd’hui à Montréal.
BCI

 
New Look Vision Group Inc. Announces Election of Directors

2018-05-10 globenewswire
MONTRÉAL, May 10, 2018 (GLOBE NEWSWIRE) -- New Look Vision Group Inc. (TSX:BCI) (“New Look Vision”) announced today that the nominees listed in the management information circular dated March 29, 2018 were elected as directors of New Look Vision. The detailed results of the vote for the election of directors held at the Annual Meeting of Shareholders of New Look Vision earlier today in Montréal are set out below.
BCI

 
Groupe Vision New Look inc. annonce des résultats record pour le premier trimestre de 2018

2018-05-09 globenewswire
MONTRÉAL, 09 mai 2018 (GLOBE NEWSWIRE) -- Groupe Vision New Look Inc. (TSX:BCI) (« Vision New Look » ou la « société ») a annoncé aujourd’hui ses résultats financiers pour les 13 semaines terminées le 31 mars 2018. Groupe Vision New Look est un chef de fil dans le commerce canadien de vente au détail de l’optique avec 376 magasins à travers le Canada. Ce communiqué devrait être lu à la lumière du rapport de gestion et des états financiers consolidés intermédiaires résumés du premier trimestre de 2018, lesquels sont disponibles sur le site de la société à www.
BCI

 
New Look Vision Group Inc Reports Record Results for the First Quarter of 2018

2018-05-09 globenewswire
MONTRÉAL, May 09, 2018 (GLOBE NEWSWIRE) -- New Look Vision Group Inc. ("New Look Vision" or the "Company") (TSX:BCI), a leader in the Canadian retail optical business with 376 stores across Canada, reported financial results today for the 13 weeks ended March 31, 2018 (“Q1 2018”). This press release should be read in conjunction with the Company’s management discussion and analysis (the “MD&A") and interim consolidated financial statements for Q1 2018, which are available on the Company’s website at www.
BCI

 
New Look Vision Group Inc. to Hold First Quarter 2018 Results conference Call

2018-05-04 globenewswire
MONTREAL, May 04, 2018 (GLOBE NEWSWIRE) -- New Look Vision Group Inc. (TSX:BCI) ("New Look") announced today that it will present its first quarter results for 2018 during a conference call on Thursday, May 10th, 2018 at 1:00 p.m. EDT for the financial community. The financial results will be made public in a press release that will be issued on the newswire prior to the conference call. The Press Release and the Management’s Discussion & Analysis will be posted SEDAR (www.
BCI

 
Appel conférence du Groupe Vision New Look inc.:  Résultats premier trimestre de l’exercice financier 2018

2018-05-04 globenewswire
MONTRÉAL, 04 mai 2018 (GLOBE NEWSWIRE) -- Le jeudi 10 mai prochain à 13h00 (HAE), le Groupe Vision New Look inc. (TSX:BCI) (« New Look ») présentera ses résultats financiers du premier trimestre 2018 lors d’une conférence téléphonique pour la communauté financière. L’annonce des résultats financiers se fera par le biais d’un communiqué qui sera diffusé sur le fil de presse avant la conférence téléphonique.
BCI

 
Groupe Vision New Look inc. annonce ses résultats records pour le quatrième trimestre et l’exercice financier 2017

2018-03-21 globenewswire
MONTRÉAL, 20 mars 2018 (GLOBE NEWSWIRE) -- Groupe Vision New Look Inc. (TSX:BCI) (« Vision New Look ») a annoncé aujourd’hui ses résultats financiers pour les 13 et 52 semaines terminées le 30 décembre 2017. Groupe Vision New Look est un chef de fil dans le commerce canadien de l’optique avec 379 magasins à travers le Canada. Ce communiqué devrait être lu à la lumière du rapport de gestion et des états financiers consolidés pour l’exercice 2017, lesquels sont disponibles sur le site de la société à www.
BCI

 
New Look Vision Group Inc. Reports Record Results for the Fourth Quarter and Year End for Fiscal 2017

2018-03-21 globenewswire
MONTRÉAL, March 20, 2018 (GLOBE NEWSWIRE) -- New Look Vision Group Inc. ("New Look Vision" or the ‘Company’) (TSX:BCI), a leader in the Canadian optical business with 379 stores across Canada, reported financial results today for the 13 and 52 weeks ended December 30, 2017 (“Q4 2017” and “fiscal 2017”). This press release should be read in conjunction with the Company’s management discussion and analysis (the “MD&A") and consolidated financial statements for fiscal 2017, which are available on the Company’s website at www.
BCI

7
New Look Vision Group - A Closer Look At A Rising Presence

2018-03-14 seekingalpha
New Look Vision's growth strategy will allow them to take advantage of their economies of scale, as well as secure its position within the increasingly consolidated industry of optical retail.
EYE SAFLF BOSSY FLMNY KATE SAFLY HUGPF FLMNF BCI LUXTY

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...